Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs
| Autor: | Joachim Kugler, Steffen Behrens, Denise Weber, Jasmin Ortak, Erdal Safak, Fatih Arslan, Harald Darius, Stephan Kische, Giuseppe D Ancona, Hüseyin Ince, Dietlind Zohlenhöfer-Momm |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Cardiac Catheterization Percutaneous Risk profile Left atrial Internal medicine Germany Atrial Fibrillation Medicine Humans Atrial Appendage Aged Fibrillation business.industry Atrial fibrillation General Medicine Prostheses and Implants medicine.disease Hospitalization Median time Hospitalization cost Cardiology Costs and Cost Analysis Female medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | Clinical research in cardiology : official journal of the German Cardiac Society. 111(1) |
| ISSN: | 1861-0692 |
| Popis: | To report hospitalization costs of patients with non-valvular atrial fibrillation (AF) submitted to percutaneous left atrial appendage closure (LAAC) with the Watchman device. Pre- and post-procedural hospitalization AF-related costs were calculated using the DRG system (diagnosis-related groups) and compared. Between 2012 and 2016, 677 non-valvular AF patients underwent LAAC. Median time from first cardiac hospitalization to LAAC was 5.9 years (IQR 1.6–9.1) and median follow-up after LAAC was 4.8 years (IQR 3.6–5.6). LAAC mortality was 1.3% and follow-up mortality 16.9%. Median pre-LAAC hospitalization cost was € 17,867 (IQR € 7512–35,08) and post-LAAC € 8772 (IQR € 1183–25,159) (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink